BlackRock
JUNS

BlackRock’s Jupiter Neurosciences JUNS Stock Holding History

BlackRock’s Portfolio JUNS Stock Details JUNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-170
Closed -$7.76K – 5620
2025
Q1 		$7.76K Buy
+170
New +$27.6K ﹤0.01% 5200

Other funds holding JUNS

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BlackRock's JUNS Position: Q2 2025 in Review

BlackRock sold out of Jupiter Neurosciences (JUNS) in Q2 2025, closing a stake of 170 shares — an estimated $7.76K sold.

BlackRock first reported a position in JUNS in Q1 2025 and held it in 1 quarter. The position peaked at $7.76K in Q1 2025. 2 funds tracked by Wall St. Rank hold JUNS as of Q2 2025.

  • BlackRock reported no remaining Jupiter Neurosciences position as of Q2 2025 after selling out during the quarter.
  • BlackRock sold 170 Jupiter Neurosciences shares in Q2 2025, an estimated $7.76K.
  • BlackRock first reported a position in Jupiter Neurosciences in Q1 2025 and held it in 1 quarter.
  • BlackRock's Jupiter Neurosciences position peaked at $7.76K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q2 2025.

Based on BlackRock's 13F filing for Q2 2025, filed 12 Aug 2025.